Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17223862rdf:typepubmed:Citationlld:pubmed
pubmed-article:17223862lifeskim:mentionsumls-concept:C1457887lld:lifeskim
pubmed-article:17223862lifeskim:mentionsumls-concept:C0025914lld:lifeskim
pubmed-article:17223862lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:17223862lifeskim:mentionsumls-concept:C0026336lld:lifeskim
pubmed-article:17223862lifeskim:mentionsumls-concept:C1334879lld:lifeskim
pubmed-article:17223862lifeskim:mentionsumls-concept:C0011615lld:lifeskim
pubmed-article:17223862lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:17223862lifeskim:mentionsumls-concept:C0243077lld:lifeskim
pubmed-article:17223862pubmed:issue2lld:pubmed
pubmed-article:17223862pubmed:dateCreated2007-1-16lld:pubmed
pubmed-article:17223862pubmed:abstractTextNerve growth factor (NGF) is an important substance in the skin, where it modulates nerve maintenance and repair. However, the direct link between NGF and pruritic diseases such as atopic dermatitis is not yet fully understood. Our previous study showed that NGF plays an important role in the pathogenesis of atopic dermatitis-like skin lesions in NC/Nga mice. NGF mediates its effects by binding to two classes of transmembrane receptors, a high-affinity receptor (tropomyosin-related kinase A, TrkA) and a low-affinity receptor (p75).lld:pubmed
pubmed-article:17223862pubmed:languageenglld:pubmed
pubmed-article:17223862pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17223862pubmed:citationSubsetIMlld:pubmed
pubmed-article:17223862pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17223862pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17223862pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17223862pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17223862pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17223862pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17223862pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17223862pubmed:statusMEDLINElld:pubmed
pubmed-article:17223862pubmed:monthFeblld:pubmed
pubmed-article:17223862pubmed:issn0007-0963lld:pubmed
pubmed-article:17223862pubmed:authorpubmed-author:SakuraiTTlld:pubmed
pubmed-article:17223862pubmed:authorpubmed-author:TakanoNNlld:pubmed
pubmed-article:17223862pubmed:authorpubmed-author:OhashiYYlld:pubmed
pubmed-article:17223862pubmed:authorpubmed-author:KurachiMMlld:pubmed
pubmed-article:17223862pubmed:issnTypePrintlld:pubmed
pubmed-article:17223862pubmed:volume156lld:pubmed
pubmed-article:17223862pubmed:ownerNLMlld:pubmed
pubmed-article:17223862pubmed:authorsCompleteYlld:pubmed
pubmed-article:17223862pubmed:pagination241-6lld:pubmed
pubmed-article:17223862pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:17223862pubmed:meshHeadingpubmed-meshheading:17223862...lld:pubmed
pubmed-article:17223862pubmed:meshHeadingpubmed-meshheading:17223862...lld:pubmed
pubmed-article:17223862pubmed:meshHeadingpubmed-meshheading:17223862...lld:pubmed
pubmed-article:17223862pubmed:meshHeadingpubmed-meshheading:17223862...lld:pubmed
pubmed-article:17223862pubmed:meshHeadingpubmed-meshheading:17223862...lld:pubmed
pubmed-article:17223862pubmed:meshHeadingpubmed-meshheading:17223862...lld:pubmed
pubmed-article:17223862pubmed:meshHeadingpubmed-meshheading:17223862...lld:pubmed
pubmed-article:17223862pubmed:meshHeadingpubmed-meshheading:17223862...lld:pubmed
pubmed-article:17223862pubmed:meshHeadingpubmed-meshheading:17223862...lld:pubmed
pubmed-article:17223862pubmed:meshHeadingpubmed-meshheading:17223862...lld:pubmed
pubmed-article:17223862pubmed:meshHeadingpubmed-meshheading:17223862...lld:pubmed
pubmed-article:17223862pubmed:meshHeadingpubmed-meshheading:17223862...lld:pubmed
pubmed-article:17223862pubmed:meshHeadingpubmed-meshheading:17223862...lld:pubmed
pubmed-article:17223862pubmed:meshHeadingpubmed-meshheading:17223862...lld:pubmed
pubmed-article:17223862pubmed:year2007lld:pubmed
pubmed-article:17223862pubmed:articleTitleEffects of high-affinity nerve growth factor receptor inhibitors on symptoms in the NC/Nga mouse atopic dermatitis model.lld:pubmed
pubmed-article:17223862pubmed:affiliationPharmacological Evaluation Laboratory, Self Medication Laboratories, Medicinal Development Research Laboratories, Taisho Pharmaceutical Co Ltd, Saitama City, Saitama, Japan. n.takano@po.rd.taisho.co.jplld:pubmed
pubmed-article:17223862pubmed:publicationTypeJournal Articlelld:pubmed
entrez-gene:59109entrezgene:pubmedpubmed-article:17223862lld:entrezgene